Novel HIV-1 Integrase Inhibitors Derived from Quinolone Antibiotics
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
The viral enzyme integrase is essential for the replication of human immunodeficiency virus type 1 (HIV-1) and represents a remaining target for antiretroviral drugs. Here, we describe the modification of a quinolone antibiotic to produce the novel integrase inhibitor JTK-303 (GS 9137) that blocks strand transfer by the viral enzyme. It shares the core structure of quinolone antibiotics, exhibits an IC50 of 7.2 nM in the strand transfer assay, and shows an EC50 of 0.9 nM in an acute HIV-1 infection assay.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the last 14 years, four more INSTIs were approved for treatment of HIV infection: elvitegravir, dolutegravir, bictegravir and cabotegravir147–150.”
From Structure and function of retroviral integrase (2022) · cites this paper as [147]
Citations
Cites
Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds
Pauwels, R., Balzarini, J., Baba, M., Snoeck, R., Schols, D., Herdewijn, P., Desmyter, J., & De Clercq, E. (1988) · Journal of Virological Methods · doi:10.1016/0166-0934(88)90134-6 · Cited by 1,642
Inhibitors of Strand Transfer That Prevent Integration and Inhibit HIV-1 Replication in Cells
Hazuda, D. J., Felock, P., Witmer, M., Wolfe, A., Stillmock, K., Grobler, J. A., Espeseth, A., Gabryelski, L., Schleif, W., Blau, C., et al. (2000) · Science · doi:10.1126/science.287.5453.646 · Cited by 1,131
Integrase inhibitors to treat HIV/Aids
Pommier, Y., Johnson, A. A., & Marchand, C. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1660 · Cited by 688
Goldgur, Y., Craigie, R., Cohen, G. H., Fujiwara, T., Yoshinaga, T., Fujishita, T., Sugimoto, H., Endo, T., Murai, H., & Davies, D. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13040 · Cited by 496
Acquired Dendritic Channelopathy in Temporal Lobe Epilepsy
Bernard, C., Anderson, A., Becker, A., Poolos, N. P., Beck, H., & Johnston, D. (2004) · Science · doi:10.1126/science.1097065 · Cited by 449
Richman, D. D. (2001) · Nature · doi:10.1038/35073673 · Cited by 419
Grobler, J. A., Stillmock, K., Hu, B., Witmer, M., Felock, P., Espeseth, A. S., Wolfe, A., Egbertson, M., Bourgeois, M., Melamed, J., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092056199 · Cited by 399
A Tale of Two Futures: HIV and Antiretroviral Therapy in San Francisco
Blower, S. M., Gershengorn, H. B., & Grant, R. M. (2000) · Science · doi:10.1126/science.287.5453.650 · Cited by 390
Hazuda, D. J., Anthony, N. J., Gomez, R. P., Jolly, S. M., Wai, J. S., Zhuang, L., Fisher, T. E., Embrey, M., Guare, J. P., Egbertson, M. S., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402357101 · Cited by 333
The Synthesis of Certain Substituted Quinolines and 5,6-Benzoquinolines
Gould, R. G., & Jacobs, W. A. (1939) · Journal of the American Chemical Society · doi:10.1021/ja01265a088 · Cited by 307
Research works printed but not linked: 4
- Barreca M. L., 2005, J. Med. Chem., 48, 7088
- Zhuang L., 2003, J. Med. Chem., 46, 456
- Anthony N. J., 2002, Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors. PCT Int. Appl. WO02/30930 A2
- Cecchetti V., 1996, J. Med. Chem., 39, 445
Cited by
Items 101–200 of 358
Recent Advances in the Discovery of Small-Molecule Inhibitors of HIV-1 Integrase
Choi, E., Mallareddy, J. R., Lu, D., & Kolluru, S. (2018) · Future Science OA · doi:10.4155/fsoa-2018-0060 · Cited by 51
Ramkumar, K., Tambov, K. V., Gundla, R., Manaev, A. V., Yarovenko, V. N., Traven, V. F., & Neamati, N. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.08.067 · Cited by 41
Molecular docking, QPLD, and ADME prediction studies on HIV-1 integrase leads
Tripathi, S. K., Selvaraj, C., Singh, S. K., & Reddy, K. K. (2012) · Medicinal Chemistry Research · doi:10.1007/s00044-011-9940-6 · Cited by 44
Targeting HIV-1 integrase with strand transfer inhibitors
Li, Y., Xuan, S., Feng, Y., & Yan, A. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.12.001 · Cited by 44
HIV Drug Resistance and the Advent of Integrase Inhibitors
Quashie, P. K., Mésplède, T., & Wainberg, M. A. (2012) · Current Infectious Disease Reports · doi:10.1007/s11908-012-0305-1 · Cited by 46
HIV-1 integrase inhibitors: 2007-2008 update
Ramkumar, K., Serrao, E., Odde, S., & Neamati, N. (2010) · Medicinal Research Reviews · doi:10.1002/med.20194 · Cited by 42
Marchand, C., Beutler, J. A., Wamiru, A., Budihas, S. R., Möllmann, U., Heinisch, L., Mellors, J. W., Grice, S. F. L., & Pommier, Y. G. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00883-07 · Cited by 39
Ferro, S., Luca, L. D., Barreca, M. L., Iraci, N., Grazia, S. D., Christ, F., Witvrouw, M., Debyser, Z., & Chimirri, A. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8009266 · Cited by 40
Urvashi, U., Kumar, J. B. S., Das, P., & Tandon, V. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00444 · Cited by 40
Xue, W., Liu, H., & Yao, X. (2011) · Journal of Computational Chemistry · doi:10.1002/jcc.22887 · Cited by 39
Authentic HIV-1 Integrase Inhibitors
Liao, C., Marchand, C., Burke, T. R., Pommier, Y. G., & Nicklaus, M. C. (2010) · Future Medicinal Chemistry · doi:10.4155/fmc.10.199 · Cited by 37
Luca, L. D., Barreca, M. L., Ferro, S., Iraci, N., Michiels, M., Christ, F., Debyser, Z., Witvrouw, M., & Chimirri, A. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.03.089 · Cited by 35
Carcelli, M., Rogolino, D., Gatti, A. M., Pala, N., Corona, A., Caredda, A., Tramontano, E., Pannecouque, C. C., Naesens, L. M. J., & Esposito, F. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00440 · Cited by 36
Goethals, O., Ginderen, M. V., Vos, A. M., Cummings, M. D., der Borght, K. V., Wesenbeeck, L. V., Feyaerts, M., Verheyen, A., Smits, V., Loock, M. V., et al. (2011) · Antiviral Research · doi:10.1016/j.antiviral.2011.05.011 · Cited by 38
Dynamic Oligomerization of Integrase Orchestrates HIV Nuclear Entry
Borrenberghs, D., Dirix, L., Wit, F. D., Rocha, S., Blokken, J., Houwer, S. D., Gijsbers, R., Christ, F., Hofkens, J., Hendrix, J., et al. (2016) · Scientific Reports · doi:10.1038/srep36485 · Cited by 38
Tandon, V., Urvashi, U., Yadav, P., Sur, S., Abbat, S., Tiwari, V., Hewer, R., Papathanasopoulos, M. A., Raja, R., Banerjea, A. C., et al. (2015) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5b00230 · Cited by 33
HIV type 1 integrase inhibitors: from basic research to clinical implications.
Jegede, O., Babu, J., Santo, R. D., McColl, D. J., Weber, J., & Quiñones‐Mateu, M. E. (2008) · PubMed · Cited by 45
Ruthenium arene complexes as HIV-1 integrase strand transfer inhibitors
Carcelli, M., Bacchi, A., Pelagatti, P., Rispoli, G., Rogolino, D., Sanchez, T. W., Sechi, M., & Neamati, N. (2012) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2012.09.021 · Cited by 32
Scaffold rearrangement of dihydroxypyrimidine inhibitors of HIV integrase: Docking model revisited
Tang, J. Y., Maddali, K., Pommier, Y. G., Sham, Y. Y., & Wang, Z. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.04.048 · Cited by 33
Mechanisms and inhibition of HIV integration
Marchand, C., Johnson, A. A., Семенова, Е. А., & Pommier, Y. G. (2006) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2006.05.004 · Cited by 49
Sugiyama, S., Akiyama, T., Taoda, Y., Iwaki, T., Matsuoka, E., Akihisa, E., Seki, T., Yoshinaga, T., & Kawasuji, T. (2020) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2020.127742 · Cited by 31
Zhao, X. Z., Maddali, K., Vu, B. C., Marchand, C., Hughes, S. H., Pommier, Y. G., & Burke, T. R. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.03.122 · Cited by 31
Gore, B. S., Lee, C. C., Lee, J. T., & Wang, J. (2019) · Advanced Synthesis & Catalysis · doi:10.1002/adsc.201900286 · Cited by 31
Iodine/persulfate-promoted site-selective direct thiolation of quinolones and uracils
Beukeaw, D., Noikham, M., & Yotphan, S. (2019) · Tetrahedron · doi:10.1016/j.tet.2019.130537 · Cited by 30
QSAR study of carboxylic acid derivatives as HIV-1 Integrase inhibitors
Cheng, Z., Zhang, Y., & Fu, W. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.05.052 · Cited by 30
Fluorine in anti-HIV drugs approved by FDA from 1981 to 2023
Han, S., & Lu, Y. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115586 · Cited by 30
Wang, P., Liu, C., Sanches, T., Zhong, Y., Liu, B., Xiong, J., Neamati, N., & Zhao, G. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.06.100 · Cited by 29
Synthesis and HIV-1 integrase inhibitory activity of spiroundecane(ene) derivatives
Shults, E. E., Семенова, Е. А., Johnson, A. A., Bondarenko, S. P., Bagryanskaya, I. Y., Gatilov, Y. V., Tolstikov, G. A., & Pommier, Y. G. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.11.094 · Cited by 29
Metal‐Free and Visible‐Light‐Promoted C‐3 Thiocyanation of 2‐Arylquinolin‐4‐ones
Chauhan, P., Ritu, Preeti, P., Kumar, S., & Jain, N. (2019) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201900349 · Cited by 28
Advances in the development of HIV integrase strand transfer inhibitors
Wang, Y., Gu, S., He, Q., & Fan, R. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113787 · Cited by 29
Anti-HIV diarylpyrimidine–quinolone hybrids and their mode of action
Mao, T.-Q., He, Q., Wan, Z.-Y., Chen, W., Chen, F., Tang, G., Clercq, E. D., Daelemans, D., & Pannecouque, C. C. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.03.037 · Cited by 28
Ping, X.-N., Wei, P., Zhu, X., & Xie, J. (2017) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.6b02688 · Cited by 28
Ghosh, P., Chhetri, G., Nandi, A. K., Sarkar, S., Saha, T., & Das, S. (2019) · New Journal of Chemistry · doi:10.1039/c9nj01922g · Cited by 28
Homology Model-Guided 3D-QSAR Studies of HIV-1 Integrase Inhibitors
Sharma, H., Cheng, X., & Buolamwini, J. K. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci200485a · Cited by 29
The future of integrase inhibitors of HIV-1
Malet, I., Cálvez, V., & Marcelin, A. (2012) · Current Opinion in Virology · doi:10.1016/j.coviro.2012.08.005 · Cited by 33
Nagasawa, J. Y., Song, J. Z., Chen, H., Kim, H.-W., Blazel, J. K., Ouk, S., Gröschel, B., Borges, V. F., Ong, V. S., Yeh, L., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.11.108 · Cited by 27
Tintori, C., Manetti, F., Veljković, N., Perović, V., Vercammen, J., Hayes, S., Massa, S., Witvrouw, M., Debyser, Z., Veljković, V., et al. (2007) · Journal of Chemical Information and Modeling · doi:10.1021/ci700078n · Cited by 27
Recent Updates on Viral Oncogenesis: Available Preventive and Therapeutic Entities
Chowdhary, S., Deka, R., Panda, K., Kumar, R., Solomon, A. D., Das, J., Kanoujiya, S. N., Gupta, A. K., Sinha, S., Ruokolainen, J., et al. (2023) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c01080 · Cited by 33
Role of integrase inhibitors in the treatment of HIV disease
Palmisano, L. (2007) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.5.1.67 · Cited by 26
Yang, Z., Yang, X., Deng, X., Wei, S., Liu, J., Ma, J., Zhao, Q., & Huo, Y. (2021) · Infection · doi:10.1007/s15010-021-01668-9 · Cited by 25
HIV-1 Integrase Inhibitors: A Review of Their Chemical Development
Ingale, K. B., & Bhatia, M. S. (2011) · Antiviral chemistry & chemotherapy · doi:10.3851/imp1740 · Cited by 32
Vandurm, P., Guiguen, A., Cauvin, C., Georges, B., Van, K. L., Michaux, C., Cardona, C., Mbemba, G., Mouscadet, J. F., Hevesi, L., et al. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.02.028 · Cited by 25
Bosch, L., & Vilarrasa, J. (2007) · Angewandte Chemie · doi:10.1002/ange.200605095 · Cited by 26
Evidence and controversies on the role of XMRV in prostate cancer and chronic fatigue syndrome
Menéndez‐Arias, L. (2010) · Reviews in Medical Virology · doi:10.1002/rmv.673 · Cited by 26
The preclinical discovery and development of dolutegravir for the treatment of HIV
Bailly, F., & Cotelle, P. (2015) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2015.1064896 · Cited by 26
Pandey, K. K., Bera, S., Vora, A. C., & Grandgenett, D. P. (2010) · Biochemistry · doi:10.1021/bi100514s · Cited by 22
Antiretroviral activity of metal-chelating HIV-1 integrase inhibitors
Carcelli, M., Rogolino, D., Sechi, M., Rispoli, G., Fisicaro, E., Compari, C., Grandi, N., Corona, A., Tramontano, E., Pannecouque, C. C., et al. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.06.055 · Cited by 23
Adhikari, N., Halder, A. K., Mondal, C., & Jha, T. (2013) · Medicinal Chemistry Research · doi:10.1007/s00044-013-0897-5 · Cited by 22
Huang, X., Luo, R., Hu, X.-L., Chen, H., Xiang, S.-Y., Tang, C.-R., Zhang, C., Shen, X.-N., & Zheng, Y. (2020) · Current HIV Research · doi:10.2174/1570162x18666200620211922 · Cited by 21
Practical synthesis of quinolone drugs via a novel TsCl-mediated domino reaction sequence
Lei, J., Ding, Y., Zhou, H., Gao, X., Cao, Y.-H., Tang, D., Li, H., Xu, Z., & Chen, Z. (2022) · Green Chemistry · doi:10.1039/d2gc01689c · Cited by 22
DExD/H-box helicases in HIV-1 replication and their inhibition
Heaton, S. M., Gorry, P. R., & Borg, N. A. (2022) · Trends in Microbiology · doi:10.1016/j.tim.2022.11.001 · Cited by 21
Synthesis of 6-aryl substituted 4-quinolones via Suzuki cross coupling
Gupta, S., Ghosh, P., Dwivedi, S., & Das, S. (2013) · RSC Advances · doi:10.1039/c3ra45056b · Cited by 22
Discovery of MK‐8970: An Acetal Carbonate Prodrug of Raltegravir with Enhanced Colonic Absorption
Walji, A. M., Sánchez, R. I., Clas, S., Nofsinger, R., Ruiz, M. D. L., Li, J., Bennet, A., John, C., Bennett, D. J., Sanders, J. M., et al. (2014) · ChemMedChem · doi:10.1002/cmdc.201402393 · Cited by 22
A “Thiocarbonyl‐Directed” Regiospecific C−H/S−H Annulation of Quinoline‐4(1 H )‐thiones with Alkynes
Modi, A., Sau, P., Chakraborty, N., & Patel, B. K. (2019) · Advanced Synthesis & Catalysis · doi:10.1002/adsc.201801537 · Cited by 22
Developing 2D-QSAR models for naphthyridine derivatives against HIV-1 integrase activity
Zakariazadeh, M., Barzegar, A., Soltani, S., & Aryapour, H. (2014) · Medicinal Chemistry Research · doi:10.1007/s00044-014-1305-5 · Cited by 21
Biological evaluation of imidazolium- and ammonium-based salts as HIV-1 integrase inhibitors
Maddali, K., Kumar, V., Marchand, C., Pommier, Y. G., & Malhotra, S. V. (2010) · MedChemComm · doi:10.1039/c0md00201a · Cited by 21
Wei, P., Wang, M., Xu, D., & Xie, J. (2016) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.5b02369 · Cited by 21
Alshammari, M. B., Ramadan, M. A., Aly, A. A., El‐Sheref, E. M., Bakht, M. A., Ibrahim, M. A. A., & Shawky, A. M. (2020) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2020.129649 · Cited by 21
Daelemans, D., Lu, R., Clercq, E. D., & Engelman, A. (2007) · Journal of Virology · doi:10.1128/jvi.02637-06 · Cited by 23
Hu, L., Song, Y., Luo, Z., Xiao, H., Wang, Y., Wang, Z., & Zeng, C. (2012) · Molecules · doi:10.3390/molecules170910652 · Cited by 20
Computer Tools in the Discovery of HIV-1 Integrase Inhibitors
Liao, C., & Nicklaus, M. C. (2010) · Future Medicinal Chemistry · doi:10.4155/fmc.10.193 · Cited by 21
C-6 aryl substituted 4-quinolone-3-carboxylic acids as inhibitors of hepatitis C virus
Chen, Y.-L., Zacharias, J., Vince, R., Geraghty, R. J., & Wang, Z. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.05.066 · Cited by 25
Drug 9AA reactivates p21/Waf1 and Inhibits HIV-1 progeny formation
Wu, W., Kehn‐Hall, K., Pedati, C., Zweier, L., Castro, I., Klase, Z. A., Dowd, C. S., Dubrovsky, L., Bukrinsky, M., & Kashanchi, F. (2008) · Virology Journal · doi:10.1186/1743-422x-5-41 · Cited by 20
Baelen, K. V., Rondelez, E., Eygen, V. V., Ariën, K. K., Clynhens, M., den Zegel, P. V., Winters, B., & Stuyver, L. J. (2009) · Journal of Virological Methods · doi:10.1016/j.jviromet.2009.06.015 · Cited by 19
Gusarova, N. K., Volkov, P. А., Ivanova, N. I., Khrapova, K. O., Albanov, A. I., Afonin, A. V., Borodina, T. N., & Trofimov, B. A. (2016) · Tetrahedron Letters · doi:10.1016/j.tetlet.2016.07.024 · Cited by 19
The successes and failures of HIV drug discovery
Hashimoto, C., Tanaka, T., Narumi, T., Nomura, W., & Tamamura, H. (2011) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2011.611129 · Cited by 19
Dynamics of Raltegravir Resistance Profile in an HIV Type 2-Infected Patient
Xu, L., Anderson, J., Garrett, N., Ferns, R. B., Wildfire, A., Cook, P., Workman, J., Graham, S. M., & Smit, E. (2009) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2009.0039 · Cited by 20
Hage, K. E., Piquemal, J., Hobaika, Z., Maroun, R. G., & Gresh, N. (2014) · The Journal of Physical Chemistry A · doi:10.1021/jp5079899 · Cited by 19
Photoredox halogenation of quinolones: the dual role of halo-fluorescein dyes
Ritu, Kumar, S., Chauhan, P., & Jain, N. (2021) · Organic & Biomolecular Chemistry · doi:10.1039/d1ob00538c · Cited by 17
Wainberg, M. A. (2012) · Scientifica · doi:10.6064/2012/238278 · Cited by 18
Quinolin-4-ones: Methods of Synthesis and Application in Medicine
Gach, K., Piekielna‐Ciesielska, J., Waśkiewicz, J., Krakowiak, K., Wtorek, K., & Janecka, A. E. (2025) · Molecules · doi:10.3390/molecules30010163 · Cited by 21
Rubio-García, E., Ferrando, N., Martin, N., Ballesté‐Delpierre, C., Miró, J. M., Paredes, R., Casals‐Pascual, C., & Vilà, J. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1306430 · Cited by 20
Rao, M. S., Sarkar, S., & Hussain, S. (2019) · Tetrahedron Letters · doi:10.1016/j.tetlet.2019.03.047 · Cited by 16
Gibson, R. M., Weber, J., Winner, D., Miller, M. D., & Quiñones‐Mateu, M. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104512 · Cited by 18
Hajimahdi, Z., Zabihollahi, R., Aghasadeghi, M. R., & Zarghi, A. (2019) · Current HIV Research · doi:10.2174/1570162x17666190911125359 · Cited by 19
Ohata, Y., Tomonaga, M., Watanabe, Y., Tomura, K., Kimura, K., Akaki, T., Adachi, K., Kodama, E. N., Matsuzaki, Y., & Hayashi, H. (2022) · Journal of Virology · doi:10.1128/jvi.01843-21 · Cited by 14
Self-citationThurman, A. R., Ouattara, L. A., Yousefieh, N., Anderson, P. L., Bushman, L. R., Fang, X., Hanif, H., Clark, M. R., Singh, O., & Doncel, G. F. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1130101 · Cited by 18
Chen, Q., Pan, Y., Yue, T., Yang, W., Liu, H., & Zheng, J. (2020) · Organic Letters · doi:10.1021/acs.orglett.0c02173 · Cited by 15
He, Q., Zhang, X., Yang, L., Zheng, Y., & Chen, F. (2012) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2012.668540 · Cited by 15
Structural modifications of quinolone-3-carboxylic acids with anti-HIV activity
He, Q., Gu, S., Liu, J., Wu, H.-Q., Zhang, X., Yang, L., Zheng, Y., & Chen, F. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.06.020 · Cited by 15
Zhang, D., Debnath, B., Yu, S., Sanchez, T. W., Christ, F., Liu, Y., Debyser, Z., Neamati, N., & Zhao, G. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.07.036 · Cited by 15
An Improved Synthesis of Elvitegravir
Rádl, S., Stach, J., Píša, O., Cinibulk, J., Havlı́ček, J., Zajícová, M., & Pekárek, T. (2015) · Journal of Heterocyclic Chemistry · doi:10.1002/jhet.2477 · Cited by 14
Safakish, M., Hajimahdi, Z., Aghasadeghi, M. R., Vahabpour, R., & Zarghi, A. (2019) · Current HIV Research · doi:10.2174/1570162x17666191210105809 · Cited by 19
4-Oxoquinoline Derivatives as Antivirals: A Ten Years Overview
Batalha, P. N., Forezi, L. D. S. M., Tolentino, N. M. D. C., Sagrillo, F. S., Oliveira, V. D. G., de Souza, M. C. B. V., & Boechat, F. D. C. S. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200129100219 · Cited by 14
Wang, T.-L., Liu, X., Zhang, X., Cao, B., Quan, Z., & Wang, X. (2018) · Tetrahedron Letters · doi:10.1016/j.tetlet.2018.11.008 · Cited by 14
A Novel, Broad-Acting Peptide Inhibitor of Double-Stranded DNA Virus Gene Expression and Replication
Ruzsics, Z., Hoffmann, K., Riedl, A., Krawczyk, A., Widera, M., Sertznig, H., Schipper, L., Kapper-Falcone, V., Debreczeny, M., Ernst, W., et al. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.601555 · Cited by 14
Liu, L., Li, J., Dai, W., Gao, F., Chen, K., Zhou, Y., & Liu, H. S. (2020) · Molecules · doi:10.3390/molecules25020268 · Cited by 14
Koh, Y., Haim, H., & Engelman, A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01064-10 · Cited by 13
Deshmukh, M. S., Srivastava, A., Das, B., & Jain, N. (2015) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.5b01646 · Cited by 13
Bronson, J. J., Black, A., Dhar, T. G. M., Ellsworth, B. A., & Merritt, J. R. (2014) · Annual reports in medicinal chemistry · doi:10.1016/b978-0-12-800167-7.00027-4 · Cited by 16
Tautomerism and Magnesium Chelation of HIV‐1 Integrase Inhibitors: A Theoretical Study
Liao, C., & Nicklaus, M. C. (2010) · ChemMedChem · doi:10.1002/cmdc.201000039 · Cited by 13
Zhang, Z., Wang, B., Wan, B., Yu, L., & Huang, Q. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.06.009 · Cited by 14
Hasan, P., Aneja, B., Masood, M. M., Ahmad, M. B., Yadava, U., Daniliuc, C. G., & Abid, M. (2017) · RSC Advances · doi:10.1039/c6ra28631c · Cited by 13
Classification and Design of HIV-1 Integrase Inhibitors Based on Machine Learning
Zhou, J., Hao, J., Peng, L., Duan, H., Luo, Q., Yan, H., Wan, H., Hu, Y., Li, L., Xie, Z., et al. (2021) · Computational and Mathematical Methods in Medicine · doi:10.1155/2021/5559338 · Cited by 14
Faro, L. V., de Almeida, J. M., Cirne-Santos, C. C., Giongo, V. A., Castello-Branco, L. R., Oliveira, I. D. B., Barbosa, J. E., Cunha, A. C., Ferreira, V. F., de Souza, M. C., et al. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.06.020 · Cited by 13
Synthesis and fungicidal activities of perfluoropropan-2-yl-based novel quinoline derivatives
Zai, Z., Liu, M., Liu, W., Xiang, J., Li, J., Li, Z., Liu, X., Huang, M., Liu, A., & Zheng, X. (2019) · Heterocyclic Communications · doi:10.1515/hc-2019-0002 · Cited by 13
Ballandras-Colas, A., Moreau, K., Robert, X., Confort, M.-P., Merceron, R., Haser, R., Ronfort, C., & Gouet, P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023032 · Cited by 16
Das, T., Kundu, M., Mondal, B., Ghosh, P., & Das, S. (2021) · Organic & Biomolecular Chemistry · doi:10.1039/d1ob01798e · Cited by 12
Design and synthesis of novel pyrimidone analogues as HIV-1 integrase inhibitors
Yu, S., Sanchez, T. W., Liu, Y., Yin, Y., Neamati, N., & Zhao, G. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.09.018 · Cited by 12
Metadata
- Authors
- Sato, M., Motomura, T., Aramaki, H., Matsuda, T., Yamashita, M., Ito, Y., Kawakami, H., Matsuzaki, Y., Watanabe, W., Yamataka, K., Ikeda, S., Kodama, E., Matsuoka, M., & Shinkai, H.
- Affiliations
- Kyoto University (JP)
- Central Pharmaceutical Research Institute, JT Inc., 1-1 Murasaki-cho, Takatsuki, Osaka, 569-1125, Japan, and Institute for Virus Research, Kyoto University, 53 Shogoin Kawaramachi, Sakyo-ku, Kyoto, 606-8507, Japan
- Corresponding author
- Shinkai, Hisashi
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2006-02-15
- Volume
- 49
- Issue
- 5
- Pages
- 1506-1508
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2025444624
- Cited by
- 328
- References
- 17
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 8 · 2023: 11 · 2022: 11 · 2021: 12 · 2020: 15 · 2019: 22 · 2018: 15 · 2017: 15 · 2016: 10 · 2015: 14 · 2014: 16 · 2013: 22 · 2012: 21
- FWCI
- 15.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Medicinal Chemistry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Keywords
- HIV-1 integrase inhibitors, quinolones, strand transfer inhibition, antiretroviral drug design, HIV-1 replication, acute HIV-1 infection
- MeSH terms
- Anti-Bacterial Agents, Cell Line, DNA, Viral, Humans, Structure-Activity Relationship, Quinolones, HIV-1, HIV Integrase, HIV Integrase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.